Penumbra Inc
corporate_fare Company Profile
Penumbra Inc (NYSE:PEN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for PEN at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Penumbra to be Acquired by Boston Scientific for $15 Billion, Offering Significant Premium
- Penumbra Inc. Agrees to Be Acquired by Boston Scientific for $374.00 Cash and Stock per Share
- Penumbra to be acquired by Boston Scientific for $374 per share in cash and stock
- Penumbra to be Acquired by Boston Scientific for $14.5 Billion, Offering Significant Premium
- Penumbra to be Acquired by Boston Scientific for $14.5 Billion in Cash and Stock
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$1.4B
Net Income
$177.69M
Diluted EPS
$4.52
Op. Cash Flow
$238.66M
Free Cash Flow
$174.93M
Gross Profit
$942.44M
Operating Income
$189.25M
Cash & Equivalents
$186.9M
Debt / Equity
0.00×
Net Margin
12.7%
Shares Outstanding
39.23M sh
Source: 10-K · filed 2026-02-25 · accession 0001321732-26-000007
show_chartPrice Chart
Loading chart...
feed PEN - Filings & News (Page 2)
PEN
Jan 15, 2026, 5:20 PM EST
Price at Filing:
$354.66
Real-time Price:
$319.12
Change:
-$35.54 (-10%)
Market Cap:
$12.578B
PEN
Jan 15, 2026, 5:07 PM EST
Price at Filing:
$354.66
Real-time Price:
$319.12
Change:
-$35.54 (-10%)
Market Cap:
$12.578B
PEN
Jan 15, 2026, 4:44 PM EST
Price at Filing:
$350.97
Real-time Price:
$319.12
Change:
-$31.85 (-9%)
Market Cap:
$12.578B
PEN
Jan 15, 2026, 7:49 AM EST
Price at Filing:
$355.74
Real-time Price:
$319.12
Change:
-$36.62 (-10%)
Market Cap:
$12.578B
PEN
Jan 15, 2026, 7:26 AM EST
Price at Filing:
$355.00
Real-time Price:
$319.12
Change:
-$35.88 (-10%)
Market Cap:
$12.578B
PEN
Jan 15, 2026, 7:15 AM EST
Price at Filing:
$351.00
Real-time Price:
$319.12
Change:
-$31.88 (-9%)
Market Cap:
$12.578B